Genapsys Stock

DNA Sequencing Technology

Sign up today and learn more about Genapsys Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Oxford Finance Corporation


Redwood City CA, US

Total Funding


About Genapsys Stock

GenapSys is a sequencing technology company that aims to help support the control and limit the spread of current and future outbreaks. The company's main goal is to transform research and diagnostics with an affordable, scalable genomic sequencing ecosystem.

In July 2022, Genapsys filed for Chapter 11 bankruptcy.

GenapSys was founded in 2010 and is headquartered in Redwood City, California. Notable investors include Decheng Capital, Oxford Finance Corporation, and Farallon Capital Management. 


Funding History

March 2013$8.5M
November 2013$36.5M
December 2017$86.2M
February 2021$70.6M


Chief Executive Officer

Jason Myers

Chief Financial Officer

Britton Russell


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: